GLP-1 Weight Loss Programs Compared: Price, What Is Included

GLP-1 weight-loss programs charge a monthly membership for the visits, and most bill the medicine on top. Memberships start at $19.99 a month. The lowest brand-name total is $223 a month at WeightWatchers Med+.

Lowest self-pay: $149 a month
Telehealth from, all in: $223 a month
Prescription: Required
Shortage: Some products short

Half-life and weight loss overview

How long each medicine remains in your body

Half-life in days shows how quickly the body clears half a dose, using section 12.3 from every FDA label.

What each medicine's main weight trial found about weight loss

Body weight, as a percentage. Because trials, doses and lengths vary, check each result against the placebo on its own page.

Sources (10)

FDA labels (DailyMed) 1 2 3 4 5 6 7 8 9 10.

Every legit way to get GLP-1, ranked

Your options for getting it, cheapest first
Route	Who it is for	What you pay
Ozempic: Novo Nordisk PAP	Household income at or below 200% of the federal poverty level	Free if approved
Trulicity: Lilly Cares	Household income at or below 300% of the federal poverty level	Free for up to 12 months
Ozempic: Get it through your doctor with insurance and the savings card	Commercial insurance that covers it	For up to 3 months, the cost can be as little as $25 a month
Wegovy: Through your doctor, using insurance and the savings card	Commercial insurance that covers it	As little as $25 a month
Mounjaro: Through your doctor, using insurance and the savings card	Commercial insurance that covers it	A fill of up to 3 months can start at $25
Zepbound: Get it through your doctor with insurance and the savings card	Commercial insurance that covers it	A fill of up to 3 months can start at $25
Foundayo: Get it through your doctor with insurance and the savings card	Commercial insurance that covers it	As little as $25 a month
Rybelsus: Get it through your doctor with insurance and the savings card	Commercial insurance that covers it	As little as $25 for a 1, 2 or 3-month fill
Trulicity: Get it through your doctor with insurance and the savings card	Commercial insurance that covers it	A fill of up to 3 months can start at $25

Prices checked November 2026. Each listed price links to the page where it came from.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Who qualifies

Every GLP-1 sold in the US requires a prescription. The label lists approved uses. A prescriber writes it for one of those uses:

Ozempic: Lowers blood sugar in adults with type 2 diabetes when used with diet and exercise.
Ozempic: For adults with type 2 diabetes and heart disease, it lowers the chance of heart attack, stroke, or heart-related death.
Wegovy: For adults with heart disease who also have obesity or are overweight, it lowers the chance of heart attack, stroke, or heart-related death (injection and tablets).
Wegovy: Long-term weight loss and keeping weight off, with diet and activity, for adults and for children 12 and older who have obesity, and for adults who have overweight and a weight-related condition.
For adults and children 10 and older with type 2 diabetes, Mounjaro lowers blood sugar when used with diet and exercise. The details are here.
Mounjaro reduces the likelihood of a heart attack, stroke or heart-related death among adults who have type 2 diabetes and face high risk.
Zepbound: Helps with weight loss and keeping weight off long term, when paired with diet and activity. It is for adults with obesity, or with overweight plus a weight-related condition.
Zepbound: Treats moderate to severe obstructive sleep apnea in adults with obesity.
Foundayo: Helps with weight loss and keeping weight off long term, when paired with diet and activity. It is for adults with obesity, or with overweight plus a weight-related condition.
Rybelsus lowers blood sugar in adults with type 2 diabetes when used with diet and exercise.
Rybelsus reduces the likelihood of a heart attack, stroke or heart-related death among adults who have type 2 diabetes and face high risk.
Trulicity: Lowers blood sugar in adults and children 10 and older with type 2 diabetes when used with diet and exercise.
Trulicity: For adults with type 2 diabetes, it reduces the chance of heart attack, stroke or heart-related death when they have heart disease or several heart risk factors.
Saxenda: Alongside diet and activity, it aids weight loss and helps maintain the loss over time for adults and children age 12 and up with obesity (over 60 kg), plus overweight adults with a weight-related condition.
Victoza: It lowers blood sugar for adults and children age 10 and up with type 2 diabetes when taken with diet and exercise.
Victoza reduces the likelihood of a heart attack, stroke or heart-related death among adults who have type 2 diabetes and also have heart disease.

Source: FDA label (DailyMed).

Telehealth compared

Telehealth programs for GLP-1
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Foundayo pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Wegovy pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Ozempic injectable pen (self-pay)	$199 a month	$74 a month	$273 a month
Ro	Wegovy pill, starting dose	$149 a month	$149 a month	$298 a month
Ro	Foundayo pill, starting dose	$149 a month	$149 a month	$298 a month
Hims & Hers	Wegovy pill	$149 a month	$149 a month after first month	$298 a month
Hims & Hers	Ozempic pen	$199 a month	$149 a month after first month	$348 a month
WeightWatchers Med+	Zepbound (self-pay)	$299 a month	$74 a month	$373 a month
Sesame (Success by Sesame)	Wegovy or Ozempic pen, after intro months	$349 a month	$59 a month	$408 a month
Ro	Zepbound KwikPen, starting dose	$299 a month	$149 a month	$448 a month
Ro	Wegovy pen, 1 mg to 2.4 mg	$349 a month	$149 a month	$498 a month
Hims & Hers	Zepbound	$1,899 a month	$149 a month after first month	$2,048 a month
Hims & Hers	Mounjaro	$1,899 a month	$149 a month after first month	$2,048 a month
Mochi Health	Compounded semaglutide (not FDA approved)	$60 a month	$79 a month after free first month	$139 a month
Mochi Health	Compounded tirzepatide (not FDA approved)	$90 a month	$79 a month after free first month	$169 a month
Henry Meds	Compounded liraglutide (daily injection) (not FDA approved)	$179 a month	Not listed	Included
Henry Meds	Tablets or drops containing compounded sublingual semaglutide (FDA approval has not been granted)	$179 a month	Not listed	Included
Noom Med	Microdose GLP-1Rx Program (compounded) (not FDA approved)	billed quarterly at $179 a month after first 4 weeks	Not listed	Included
Noom Med	GLP-1Rx Program (compounded semaglutide) (not FDA approved)	once the first 4 weeks are over, the rate of $249 a month is billed quarterly	Not listed	Included
Found	Compounded GLP-1 plan (not FDA approved)	$99 a month	$169 a month cash	$268 a month
Henry Meds	Compounded semaglutide (weekly injection) (not FDA approved)	$297 a month	Not listed	Included
Noom Med	GLP-1Rx Plus Program (compounded GLP-1 and GIP); the FDA has not approved the program	$299 a month, billed quarterly after the first 4 weeks	Not listed	Included

Each program's pricing page lists these prices. We earn no money from any of them.

Programs that bill for medicine through insurance or a pharmacy
Program	Membership	Type
Calibrate	$199 a month	insurance-first
PlushCare	$19.99 a month	primary care membership
Hello Alpha	$79 a month	brand only

Sources: weightwatchers.com, ro.co, hims.com, sesamecare.com.

Status of supply shortages

Semaglutide: February 21, 2025 marked the end of the injection shortage Rybelsus: discontinuation of the older tablets is under way

Each semaglutide product's supply
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

The FDA shortage list first listed it in March 2022
Shortage resolved: February 21, 2025
The deadline for state pharmacies to stop making compounded copies was April 22, 2025
Outsourcing facilities had to stop by May 22, 2025

Tirzepatide: The shortage has been resolved. The FDA confirmed this on December 19, 2024.

The shortage list first included it on December 15, 2022, added by the FDA
Shortage resolved: December 19, 2024
State pharmacies had to stop making compounded copies by February 18, 2025
Outsourcing facilities had to stop by March 19, 2025

Dulaglutide: Current FDA shortage data does not include it; Lilly reports that every Trulicity dose is available.

Liraglutide: It remains on the shortage list right now. Victoza pens have limited availability, generics are available, and Saxenda is scheduled to end in January 2027.

Liraglutide supply for each product
Product	FDA status	Availability
Victoza 6 mg/mL pen (2-pack and 3-pack)	Current	Limited Availability
Victoza back order	Current	Back order
Saxenda 6 mg/mL pen (5-pack)	To Be Discontinued	Available until January 2027
Generic liraglutide (Meitheal, Teva)	Current	Available

The FDA first added it to the shortage list on July 18, 2023

Sources: FDA, api.fda.gov, ashp.org.

Scam signals

No prescription needed: skipping the prescription means the seller is not a licensed US pharmacy
A brand price far below what the manufacturer charges: according to the source, the lowest self-pay price is $149 a month.
Sold as the brand but compounded: compounded drugs lack FDA approval, so none of them are Ozempic, Wegovy, Mounjaro or Zepbound.
Different salt forms: the active ingredient in approved medicines differs from semaglutide acetate and semaglutide sodium.
Claims equating a compounded drug with the brand: the FDA sent 30 warning letters to telehealth companies over those misleading claims.
Harm reports: 990 adverse event reports on compounded semaglutide are held by the FDA
Harm reports: more than 730 adverse event reports on compounded tirzepatide are held by the FDA
Monthly pricing that leaves out the drug itself: The FTC acted against one program for this; see the NextMed program review.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Find it in your state

Hims & Hers: Serves fewer than all 50 states
Noom Med: Does not serve all 50 states
NovoCare Pharmacy: DC, Puerto Rico and all 50 states are covered by its delivery network

More than anything else, Medicaid rules change the route. 10 state Medicaid programs now cover GLP-1s used for weight loss Select your state to view its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.